0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 9
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

2
7
14
31

PUBLISHED

2
2
5
31

PRODUCT TYPE

20
8
1
1
1

Search for: "Growth Hormone Deficiency Therapy Area Pipeline Report"

Growth Hormone Deficiency - Pipeline Review, H1 2015

Growth Hormone Deficiency - Pipeline Review, H1 2015 Summary This, ‘Growth Hormone Deficiency - Pipeline Review, H1 2015’, provides an overview of the Growth Hormone Deficiency’s therapeutic pipeline. This...

Published:  January 2015
Price:  From

Growth Hormone Deficiency - Pipeline Review, H2 2015

Growth Hormone Deficiency - Pipeline Review, H2 2015 Summary The report ‘Growth Hormone Deficiency - Pipeline Review, H2 2015’, provides an overview of the Growth Hormone Deficiency’s therapeutic...

Published:  October 2015
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  August 2016
Price:  From

Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients

GBI Research, the leading business intelligence provider, has released its latest research “Endocrinology Market to 2018-Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease...

Published:  March 2012
Price:  From

Global Biosimilars Market - Products, Applications and Regulations

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19 4bn by 2018 Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the...

Published:  November 2012
Price:  From

Braasch Biotech LLC - Product Pipeline Review - 2015

Braasch Biotech LLC - Product Pipeline Review - 2015 Summary This, ‘Braasch Biotech LLC - Product Pipeline Review - 2015’, provides an overview of the Braasch Biotech LLC’s pharmaceutical research...

Published:  April 2015
Price:  From

The World Market For Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry

The sexual disorder pharmacotherapy market is dominated by drugs indicated for erectile dysfunction which commands an estimated 78% of the total sexual disorder market valued at US$3 billion Significant...

Published:  January 2006
Price:  From

Prolor Biotech, Inc. - Product Pipeline Review - 2012

Prolor Biotech, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “PROLOR Biotech, Inc. - Product Pipeline Review - 2012” provides data on the PROLOR Biotech,...

Published:  September 2012
Price:  From

Idiopathic Short Stature - Pipeline Review, H2 2015

Idiopathic Short Stature - Pipeline Review, H2 2015 Summary The report ‘Idiopathic Short Stature - Pipeline Review, H2 2015’, provides an overview of the Idiopathic Short Stature’s therapeutic pipeline. This...

Published:  August 2015
Price:  From

Idiopathic Short Stature - Pipeline Review, H1 2015

Idiopathic Short Stature - Pipeline Review, H1 2015 Summary This, ‘Idiopathic Short Stature - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Short Stature’s therapeutic pipeline. This...

Published:  January 2015
Price:  From

The World Market for Gynaecology, 2007-2017

Spectra's World Market for Gynaecology, 2007-2017 provides a unique assessment of current developments and prospective factors that will shape the global female health market over the next decade This...

Published:  September 2007
Price:  From

Prolor Biotech, Inc. - Product Pipeline Review - 2013

Prolor Biotech, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Prolor Biotech, Inc. - Product Pipeline Review - 2013” provides data on the Prolor Biotech,...

Published:  May 2013
Price:  From

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  August 2016
Price:  From

The Protein Therapeutics Market: The Science and Business of a Growing Sector

The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and...

Published:  June 2006
Price:  From

Aeterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis Review

Aeterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  July 2016
Price:  From

Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond

Objectives of the Report The objectives of this report are to provide an in-depth analysis of the global antiageing and life enhancement therapeutic market Included in this study are analyses of key...

Published:  January 2006
Price:  From

Special Package: Current Developments in Immunotherapy Markets and Technology and Advances in Cancer Therapy

These reports analyze two dynamic areas of pharmaceutical research and development; immunotherapy and cancer therapy. Current Developments in Immunotherapy Markets and Technology Beyond congenital...

Published:  April 2001
Price: 

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

Peptide therapeutics, due to their numerous advantages such as high selectivity, stability, efficacy, safety, bioavailability and tolerability offer a number of benefits over other therapeutic classes....

Published:  February 2016
Price:  From

Advanced Drug Delivery: Technologies, Applications, and Markets, 2nd Ed.

This completely updated 2nd edition to Kalorama’s popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical...

Published:  November 2005
Price:  From

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

Published:  September 2009
Price:  From
Loading Indicator

Our Clients

  • Symantec Corporation
  • Sonoco Products Company
  • Tiffany & Co.
  • ITT Corporation
  • Exxon Mobil Corp.
  • Samsonite International S.A.
  • Kellogg's Co.